MANAGING INSULIN THERAPY: FROM HOSPITAL TO HOME

FACULTY

Jack L. Leahy, MD
Chief, Division of Endocrinology, Diabetes and Metabolism
Professor of Medicine
University of Vermont College of Medicine
Burlington, Vermont  

Read frequently asked questions submitted by your peers.

Electronic newsletter now available:
IMPROVING GLYCEMIC CONTROL IN HOSPITALIZED PATIENTS:
Strategies to Enhance Inpatient Care and Facilitate Outpatient Transitions

PURPOSE STATEMENT

This program will examine the importance of glycemic control in hospitalized patients, and discuss strategies for achieving and maintaining glycemic control in the hospital setting, as well as upon discharge.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

• Discuss the impact of uncontrolled glycemia on hospital patients and health outcomes
• Explain the rationale for early and aggressive management of hyperglycemia in hospitalized patients with diabetes
• Develop effective protocols to maintain tight glycemic control in hospital patients using insulin
• Implement strategies to successfully sustain glycemic control in patients after hospital discharge
  

TARGET AUDIENCE

This enduring CME/CE series is intended for primary healthcare professionals, including physicians, physician assistants, nurse practitioners, nurses, and pharmacists, as well as for other specialists and healthcare providers who are interested in the management of patients with diabetes.

ACCREDITATION INFORMATION

Expiration date: April 17, 2008

Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses (CBRN): Med-IQ is a provider approved by the California Board of Registered Nursing, Provider Number CEP #14745, for 1.0 Contact Hours.

Pharmacists:
1 contact hours (0.100 CEUs) of credit for pharmacists. This activity co-sponsored by Medical Education Collaborative, Inc. (MEC) and Med-IQ. MEC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE # 815-999-07-020-H01. The program is designed for all pharmacists.

                  

Other Credit Information
Nurse Practitioners:  Med-IQ is accredited by ACCME to provide continuing medical education for physicians, and will provide nurse practitioners who successfully complete the activity with a Statement of Participation indicating that the activity was designated for 1 AMA PRA Category 1 Credit^TM.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit^TM for the PRA from organizations accredited by ACCME.

Disclosure Policy
It is the policy of Med-IQ that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during presentation(s). Individuals who refuse to disclose will be disqualified from all aspects associated with this CME activity. Med-IQ has policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Jack Leahy, MD
Consulting fees/advisory boards: sanofi-aventis U.S.
Fees received for promotional/non-CME activities: Merck & Co., Inc.

Med-IQ Disclosure
Reshma Carter has disclosed that her spouse is an employee of Novartis Pharmaceuticals.

All other employees of Med-IQ have no financial relationships to disclose.

MEC Disclosure
The employees of Medical Education Collaborative have no financial relationships to disclose.

Acknowledgement of Commercial Support
This educational series is supported by an educational grant from sanofi-aventis U.S.